CIK 0001863006 · Accelerated filer<br>Emerging growth company
Valens Semiconductor Ltd.
Sign in to watch- Ticker
- VLN
- Exchange
- NYSE
- Industry
- Semiconductors & Related Devices
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 972-9-762-6900
- Business address
- 8 HANAGAR ST. POB 7152, HOD HASHARON, 4501309, Israel, 00000
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,072
- in 6 filings, $18K under 10b5-1 plans
Net −$33,072. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Chairman David SVP, R&D | Option exercise 10b5-1 | +278 | $0.86 | $239 | 404,246 |
| 2026-11-11 | Chairman David SVP, R&D | Sale 10b5-1 | −278 | $1.66 | $461 | 403,968 |
| 2026-11-11 | Chairman David SVP, R&D | Option exercise · Stock Option (Right to Buy) 10b5-1 | −278 | 72,182 | ||
| 2026-11-10 | Chairman David SVP, R&D | Option exercise 10b5-1 | +3,235 | $0.86 | $3K | 407,203 |
| 2026-11-10 | Chairman David SVP, R&D | Sale 10b5-1 | −3,235 | $1.66 | $5K | 403,968 |
| 2026-11-10 | Chairman David SVP, R&D | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,235 | 72,460 | ||
| 2026-06-15 | Chairman David SVP, R&D | Option exercise 10b5-1 | +4,000 | $0.86 | $3K | 407,968 |
| 2026-06-15 | Chairman David SVP, R&D | Sale 10b5-1 | −4,000 | $2.43 | $10K | 403,968 |
| 2026-06-15 | Chairman David SVP, R&D | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 75,695 | ||
| 2026-05-13 | Chairman David SVP, R&D | Option exercise 10b5-1 | +4,000 | $0.86 | $3K | 407,968 |
| 2026-05-13 | Chairman David SVP, R&D | Sale 10b5-1 | −4,000 | $2.98 | $12K | 403,968 |
| 2026-05-13 | Chairman David SVP, R&D | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 79,695 | ||
| 2026-05-08 | Chairman David SVP, R&D | Option exercise 10b5-1 | +4,000 | $0.86 | $3K | 407,968 |
| 2026-05-08 | Chairman David SVP, R&D | Sale 10b5-1 | −4,000 | $2.54 | $10K | 403,968 |
| 2026-05-08 | Chairman David SVP, R&D | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 83,695 | ||
| 2026-04-23 | Chairman David SVP, R&D | Option exercise 10b5-1 | +3,600 | $0.86 | $3K | 407,568 |
| 2026-04-23 | Chairman David SVP, R&D | Sale 10b5-1 | −3,600 | $1.67 | $6K | 403,968 |
| 2026-04-23 | Chairman David SVP, R&D | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,600 | 87,695 | ||
| 2026-04-22 | Chairman David SVP, R&D | Option exercise 10b5-1 | +400 | $0.86 | $344 | 404,368 |
| 2026-04-22 | Chairman David SVP, R&D | Sale 10b5-1 | −400 | $1.65 | $660 | 403,968 |
Page 1 of 2 · 28 trades